Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After sharp gains, Amgen slides on delayed criticism over Onyx deal
After sharp gains, Amgen slides on delayed criticism over Onyx deal
After sharp gains, Amgen slides on delayed criticism over Onyx deal
Submitted by
admin
on August 27, 2013 - 5:36pm
Source:
Marketwatch
News Tags:
Amgen
ONYX Pharmaceuticals
M&A
Headline:
After sharp gains, Amgen slides on delayed criticism over Onyx deal
Do Not Allow Advertisers to Use My Personal information
